Cite
HARVARD Citation
Cellier, C. et al. (2019). Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. Lancet gastroenterology and hepatology. pp. 960-970. [Online].